Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals

Abstract

Genes underneath signals from genome-wide association studies (GWAS) for kidney function are promising targets for functional studies, but prioritizing variants and genes is challenging. By GWAS meta-analysis for creatinine-based estimated glomerular filtration rate (eGFR) from the Chronic Kidney Disease Genetics Consortium and UK Biobank (n = 1,201,909), we expand the number of eGFRcrea loci (424 loci, 201 novel; 9.8% eGFRcrea variance explained by 634 independent signal variants). Our increased sample size in fine-mapping (n = 1,004,040, European) more than doubles the number of signals with resolved fine-mapping (99% credible sets down to 1 variant for 44 signals, ≤5 variants for 138 signals). Cystatin-based eGFR and/or blood urea nitrogen association support 348 loci (n = 460,826 and 852,678, respectively). Our customizable tool for Gene PrioritiSation reveals 23 compelling genes including mechanistic insights and enables navigation through genes and variants likely relevant for kidney function in human to help select targets for experimental follow-up.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 67

1. 1.
   Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 · 2017

   No notice
2. 2.

   James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010.

   Not in our library10.1016/s0140-6736(09)62004-3

3. 3.

   Levin A, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017.

   Not in our library10.1016/s0140-6736(17)30788-2

4. 4.

   Levey AS, et al. Nomenclature for kidney function and disease: executive summary and glossary from a kidney disease: improving global outcomes (KDIGO) consensus conference. Am. J. Kidney Dis. 2020.

   Not in our library10.1053/j.ajkd.2020.05.005

5. 5.

   Arpegård J, et al. Comparison of heritability of cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease. J. Am. Heart Assoc. 2015.

   Not in our library10.1161/jaha.114.001467

6. 6.

   Köttgen A, Pattaro C. The CKDGen Consortium: ten years of insights into the genetic basis of kidney function. Kidney Int. 2020.

   Not in our library10.1016/j.kint.2019.10.027

7. 7.

   Wuttke M, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 2019;51:957-972.

   Not in our library10.1038/s41588-019-0407-x

8. 8.

   Geddes, L. Height’s ‘missing heritability’ found. Nature 568, 444 (2019).

   Not in our library10.1038/d41586-019-01157-y

9. 9.

   Wainschtein, P. et al. Recovery of trait heritability from whole genome sequence data. Preprint at https://www.biorxiv.org/content/10.1101/588020v1 (2019).

   Not in our library

10. 10.

    Levey AS, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011.

    Not in our library10.1038/ki.2010.483

11. 11.

    Patel SS, et al. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J. Cachexia Sarcopenia Muscle. 2013.

    Not in our library10.1007/s13539-012-0079-1

12. 12.

    Stevens LA, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009.

    Not in our library10.1038/ki.2008.638

13. 13.

    Gorski M, et al. 1000 Genomes-based metaanalysis identifies 10 novel loci for kidney function. Sci. Rep. 2017.

    Not in our library10.1038/srep45040

14. 14.

    Gallagher MD, Chen-Plotkin AS. The Post-GWAS era: from association to function. Am. J. Hum. Genet. 2018.

    Not in our library10.1016/j.ajhg.2018.04.002

15. 15.

    Visscher PM, et al. 10 Years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 2017.

    Not in our library10.1016/j.ajhg.2017.06.005

16. 16.
    Functional mapping and annotation of genetic associations with FUMA · 2017

    No notice
17. 17.

    Mahajan A, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 2018;50:1505-1513.

    Not in our library10.1038/s41588-018-0241-6

18. 18.
    The UK Biobank resource with deep phenotyping and genomic data · 2018

    No notice
19. 19.

    Jiang L, et al. A resource-efficient tool for mixed model association analysis of large-scale data. Nat. Genet. 2019.

    Not in our library10.1038/s41588-019-0530-8

20. 20.

    McCarthy S, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 2016;48:1279-1283.

    Not in our library10.1038/ng.3643

21. 21.

    Walter K, et al. The UK10K project identifies rare variants in health and disease. Nature. 2015;526:82-89.

    Not in our library10.1038/nature14962

22. 22.

    Auton A, et al. A global reference for human genetic variation. Nature. 2015;526:68-74.

    Not in our library10.1038/nature15393

23. 23.

    Huffman JE. Examining the current standards for genetic discovery and replication in the era of mega-biobanks. Nat. Commun. 2018.

    Not in our library10.1038/s41467-018-07348-x

24. 24.

    Yang J, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 2012;44:369-375.

    Not in our library10.1038/ng.2213

25. 25.

    Wakefield J. A bayesian measure of the probability of false discovery in genetic epidemiology studies. Am. J. Hum. Genet. 2007.

    Not in our library10.1086/519024

26. 26.
    CADD: predicting the deleteriousness of variants throughout the human genome · 2018

    No notice
27. 27.
    Mouse Genome Database (MGD) 2019 · 2018

    No notice
28. 28.

    Hamosh, A., Scott, A. F., Amberger, J., Valle, D., & McKusick, V. A. Online Mendelian Inheritance in Man (OMIM). Hum. Mutat. https://doi.org/10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G (2000).

    Not in our library10.1002/(sici)1098-1004(200001)15:1<57::aid-humu12>3.0.co;2-g

29. 29.

    Groopman EE, et al. Diagnostic Utility of exome sequencing for kidney disease. N. Engl. J. Med. 2019.

    Not in our library10.1056/nejmoa1806891

30. 30.

    Landrum MJ, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062-D1067.

    Not in our library10.1093/nar/gkx1153

31. 31.

    Patterson LT, Pembaur M, Potter SS. Hoxa11 and Hoxd11 regulate branching morphogenesis of the ureteric bud in the developing kidney. Development. 2001;128:2153-2161.

    Not in our library10.1242/dev.128.11.2153

32. 32.

    Spahiu L, Merovci B, Jashari H, Këpuska AB, Rugova BE. Congenital nephrotic syndrome—finish type. Med. Arch. (Sarajevo, Bosnia Herzegovina). 2016.

    Not in our library10.5455/medarh.2016.70.232-234

33. 33.

    Anik A, Çatli G, Abaci A, Böber E. Maturity-onset diabetes of the young (MODY): an update. J. Pediatric Endocrinol. Metab. 2015.

    Not in our library10.1515/jpem-2014-0384

34. 34.

    Najmi LA, et al. Functional investigations of HNF1A identify rare variants as risk factors for type 2 diabetes in the general population. Diabetes. 2017;66:335-346.

    Not in our library10.2337/db16-0460

35. 35.

    Tin A, et al. Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels. Nat. Genet. 2019;51:1459-1474.

    Not in our library10.1038/s41588-019-0504-x

36. 36.

    Pontoglio M, et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell. 1996;84:575-585.

    Not in our library10.1016/s0092-8674(00)81033-8

37. 37.

    Finucane HK, et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 2018.

    Not in our library10.1038/s41588-018-0081-4

38. 38.

    Pers TH, et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 2015;6:5890.

    Not in our library10.1038/ncomms6890

39. 39.

    Stewart BJ, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019.

    Not in our library10.1126/science.aat5031

40. 40.

    Wu H, et al. Comparative analysis and refinement of human PSC-derived kidney organoid differentiation with single-cell transcriptomics. Cell Stem Cell. 2018.

    Not in our library10.1016/j.stem.2018.10.010

41. 41.
    Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics · 2014

    No notice
42. 42.

    Bulik-Sullivan B, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 2015;47:291-295.

    Not in our library10.1038/ng.3211

43. 43.

    Li, Y. et al. Integration of GWAS summary statistics and gene expression reveals target cell types underlying kidney function traits. J. Am. Soc. Nephrol.31, 2326–2340 (2020).

    Not in our library10.1681/asn.2020010051

44. 44.

    Krokstad S, et al. Cohort profile: the HUNT study, Norway. Int. J. Epidemiol. 2013.

    Not in our library10.1093/ije/dys095

45. 45.

    Stark K, et al. The German AugUR study: study protocol of a prospective study to investigate chronic diseases in the elderly. BMC Geriatr. 2015;15:130.

    Not in our library10.1186/s12877-015-0122-0

46. 46.

    Lees JS, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nat. Med. 2019.

    Not in our library10.1038/s41591-019-0627-8

47. 47.

    Traynor J, Mactier R, Geddes CC, Fox JG. How to measure renal function in clinical practice. Br. Med. J. 2006.

    Not in our library10.1136/bmj.38975.390370.7c

48. 48.

    McGuirl MR, Smith SP, Sandstede B, Ramachandran S. Detecting shared genetic architecture among multiple phenotypes by hierarchical clustering of gene-level association statistics. Genetics. 2020;215:511-529.

    Not in our library10.1534/genetics.120.303096

49. 49.

    Weighill D, et al. Multi-phenotype association decomposition: unraveling complex gene-phenotype relationships. Front. Genet. 2019;10:417.

    Not in our library10.3389/fgene.2019.00417

50. 50.

    Locke AE, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197-206.

    Not in our library10.1038/nature14177

51. 51.

    Hindorff LA, et al. Prioritizing diversity in human genomics research. Nat. Rev. Genet. 2018.

    Not in our library10.1038/nrg.2017.89

52. 52.
    Trans-ethnic genome-wide association studies: advantages and challenges of mapping in diverse populations · 2014

    No notice
53. 53.

    Pattaro C, et al. Estimating the glomerular filtration rate in the general population using different equations: effects on classification and association. Nephron Clin. Pract. 2013;123:102-111.

    Not in our library10.1159/000351043

54. 54.

    Inker LA, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 2012.

    Not in our library10.1056/nejmoa1114248

55. 55.

    Schwartz GJ, et al. Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int. 2012.

    Not in our library10.1038/ki.2012.169

56. 56.

    Stevens LA, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am. J. Kidney Dis. 2008.

    Not in our library10.1053/j.ajkd.2007.11.018

57. 57.

    Winkler TW, et al. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 2014;9:1192-1212.

    Not in our library10.1038/nprot.2014.071

58. 58.

    Devlin B, Roeder K. Genomic control for association studies. Biometrics. 1999.

    Not in our library10.1111/j.0006-341x.1999.00997.x

59. 59.

    Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190-2191.

    Not in our library10.1093/bioinformatics/btq340

60. 60.
    The Ensembl Variant Effect Predictor · 2016

    No notice
61. 61.

    Gillies CE, et al. An eQTL landscape of kidney tissue in human nephrotic syndrome. Am. J. Hum. Genet. 2018.

    Not in our library10.1016/j.ajhg.2018.07.004

62. 62.
    Genetic effects on gene expression across human tissues · 2017

    Corrected
63. 63.

    Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B. 1995.

    Not in our library10.1111/j.2517-6161.1995.tb02031.x

64. 64.

    The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science10.1126/science.aaz1776 (2020).

    Not in our library10.1126/science.aaz1776

65. 65.

    Schlosser P, et al. Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans. Nat. Genet. 2020.

    Not in our library10.1038/s41588-019-0567-8

66. 66.
    Second-generation PLINK: rising to the challenge of larger and richer datasets · 2015

    No notice
67. 67.

    Shiffman D, et al. A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND. PLoS ONE. 2014;9:1-10.

    Not in our library10.1371/journal.pone.0106631

Cited by papers we hold 2

• Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure · 2023
  No notice
• Meta-analyses identify DNA methylation associated with kidney function and damage · 2021
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.